Changes in Gut Microbial Diversity and Correlations with Clinical Outcomes in Patients with Newly Diagnosed Acute Myeloid Leukemia (AML) Receiving Intensive Chemotherapy
Sang‐Min Lee(Seoul National University), Michael J. Satlin(Cornell University), Gail J. Roboz(Cornell University), Michael Hovan(Cornell University), Caroline Andy(Cornell University), Tania J. Curcio(Cornell University), Sumaiya Miah(Cornell University), Pinkal Desai(NewYork–Presbyterian Hospital), Claire Douglass(Cornell University), Ellen K. Ritchie(Cornell University), Michael Samuel(NewYork–Presbyterian Hospital), Finola Goudy(Cornell University)
Cited by 7
Related Papers
Efficacy and Toxicity Management of 19-28z CAR T Cell Therapy in B Cell Acute Lymphoblastic Leukemia
|Science Translational Medicine|2014|2.5k
Clinical Characteristics of Covid-19 in New York City
|New England Journal of Medicine|2020|2.4k
Durable Remissions with Ivosidenib in <i>IDH1</i> -Mutated Relapsed or Refractory AML
|New England Journal of Medicine|2018|1.4k